Table 4.

miRNA in serum/plasma of ovarian cancer patients.

miRNA	Serum/Plasma	Changes in Ovarian Cancer
miR-26a	Plasma	Upregulation of miR-26a in human epithelial ovarian cancer [47]
miRNA-21 miRNA-29a miRNA-92 miRNA-93 miRNA-99b miRNA-126 miRNA-127 miRNA-155	Serum	Upregulation of miRNA-21, miRNA-29a, miRNA-92, miRNA-93, miRNA-126 in ovarian cancer [62] Downregulation of miRNA-99, miRNA-127, miRNA-155 in ovarian cancer [62]
miR-145 miR-133b	Serum	Expression of miR-145 and miR-133b is significantly decreased in the serum of patients with ovarian cancer [51]
miR-193a-5p	Serum	Combined detection of miR-193-5p, HE4 and CA125 improves the diagnostic efficacy of epithelium ovarian cancer [66]
miR-19a-3p miR-30a-5p miR-645 miR-150-5p miR-191-5p miR-206 miR-34c-5p miR-548a-3p miR-320a miR-574-3p miR-590-5p miR-106b-5p	Plasma	Downregulation of miR-19a-3p, miR-30a-5p, miR-645, miR-150-5p in ovarian cancer [67] Upregulation of miR-191-5p, miR-206, miR-34c-5p, miR-548a-3p, miR-320a, miR-574-3p, miR-590-5p, miR-106b-5p in ovarian cancer [67]